|
ACADM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.669698044386E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97230043197783E-11 |
| Normal-vs-Stage2 |
9.87040449373922E-11 |
| Normal-vs-Stage3 |
4.89369988976307E-10 |
| Normal-vs-Stage4 |
4.81470419089192E-11 |
| Stage1-vs-Stage2 |
9.817800E-01 |
| Stage1-vs-Stage3 |
7.570200E-01 |
| Stage1-vs-Stage4 |
4.166200E-01 |
| Stage2-vs-Stage3 |
8.079600E-01 |
| Stage2-vs-Stage4 |
5.659200E-01 |
| Stage3-vs-Stage4 |
8.004800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.20069542986334E-11 |
| Normal-vs-AfricanAmerican |
3.16699999558523E-11 |
| Normal-vs-Asian |
8.142000E-03 |
| Caucasian-vs-AfricanAmerican |
9.946600E-01 |
| Caucasian-vs-Asian |
6.309000E-01 |
| AfricanAmerican-vs-Asian |
6.314200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.03039832011609E-11 |
| Normal-vs-Female |
2.07279748920541E-11 |
| Male-vs-Female |
4.932600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.61204424545758E-12 |
| Normal-vs-Extreme_Weight |
1.28429489265613E-11 |
| Normal-vs-Obese |
1.37445610448594E-13 |
| Normal-vs-Extreme_Obese |
4.398900E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.161400E-01 |
| Normal_Weight-vs-Obese |
1.382380E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.606300E-02 |
| Extreme_Weight-vs-Obese |
2.020000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.073160E-01 |
| Obese-vs-Extreme_Obese |
2.186600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.6100900874535E-12 |
| Normal-vs-Age(41-60Yrs) |
2.8407054486479E-11 |
| Normal-vs-Age(61-80Yrs) |
5.75890446441463E-11 |
| Normal-vs-Age(81-100Yrs) |
9.20880000032653E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.904400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.849800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.614600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.017800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.832400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.487200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.60289567677319E-11 |
| Normal-VS-Type2 PRCC |
3.41680017612589E-10 |
| Normal-VS-KIRP CIMP |
1.88093984831994E-12 |
| Normal-VS-Unclassified PRCC |
1.20220500221535E-11 |
| Type1 PRCC-VS-Type2 PRCC |
1.378100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.355740E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.307200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.95816999999376E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.620410E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.008100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.32864896441288E-12 |
| Normal-vs-N1 |
4.67292871064728E-13 |
| Normal-vs-N2 |
2.575300E-04 |
| N0-vs-N1 |
6.772200E-02 |
| N0-vs-N2 |
3.589000E-01 |
| N1-vs-N2 |
4.957600E-01 |
|
|
